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TIRF microscopyRecent studies suggest that at low concentrations, ouabain increases Na–K ATPase and NHE1 activity and acti-
vates the Src signaling cascade in proximal tubule cells. Our laboratory demonstrated that low concentrations
of ouabain increase blood pressure in rats. We hypothesize that ouabain-induced increase in blood pressure
andNa–KATPase activity requiresNHE1 activity and association. To test this hypothesiswe treated ratswith oua-
bain (1 μg kg bodywt−1 day−1) for 9 days in the presence or absence of the NHE1 inhibitor, zoniporide. Ouabain
stimulated a signiﬁcant increase in blood pressure which was prevented by zoniporide. Using NHE1-expressing
Human Kidney cells 2 (HK2), 8 (HK8) and 11 (HK11) and Mouse Kidney cells from Wild type (WT) and NHE1
knock-out mice (SWE) cell lines, we show that ouabain stimulated Na–K ATPase activity and surface expression
in a Src-dependent manner in NHE1-expressing cells but not in NHE1-deplete cells. Zoniporide prevented
ouabain-induced stimulation of 86Rb uptake in the NHE1-expressing cells. FRET and TIRF microscopy showed
that ouabain increased association between GFP-NHE1 and mCherry-Na–K ATPase transfected into NHE1-
deﬁcient SWE cells. Mutational analysis demonstrated that the caveolin binding motif (CBM) of Na–K ATPase
α1 is required for translocation of both Na–K ATPase α1 and NHE1 to the basolateral membrane. Mutations in
activity or scaffold domains of NHE1 resulted in loss of ouabain-mediated regulation of Na–K ATPase. These re-
sults support that NHE1 is required for the ouabain-induced increase in blood pressure, and that the caveolin
binding motif of Na–K ATPase α1 as well as the activity and scaffolding domains of NHE1 are required for their
functional association.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Na–K ATPase plays two separate roles in cell metabolism. Its best
known function is as themediator of sodium–potassium exchange, reg-
ulating intracellular ion content and transepithelial ionmovement [1,2].
This process is highly regulated and speciﬁcally inhibited by cardiac gly-
cosides,which are used pharmacologically in the treatment of heart fail-
ure and cardiac arrhythmias [3,4]. Within the past decade, a second
function for Na–K ATPase has been described, as it being a receptor for
cardiac glycoside-stimulated signal transduction through an EGFR/Src/
ERK-dependent pathway [4–7]. Whether cardiac glycoside stimulation
results in Na–K exchange or activation of ERK appears to be a function
of the concentration of the cardiac glycoside, in that the pharmacologic02 S. Pod, Louisville, KY 40202,
undmiri).doses used for treatment of heart failure inhibit ion exchange, whereas
much lower physiologic concentrations actually stimulate ion exchange
and the EGFR/Src/ERK signaling pathway [8,9]. The physiologic role for
cardiac glycoside-stimulated sodium pump activity remains unclear.
Furthermore, this function may also be speciﬁc to some but not all
Na–K isoforms.
We have recently demonstrated that low concentrations of ouabain,
a well-studied cardiac glycoside, stimulate Na–K ATPase-mediated
ATPase activity, 86Rb uptake, andNa–K ATPaseα1 subunit phosphoryla-
tion and trafﬁcking to the basolateral membrane of renal proximal tu-
bule cells [10]. Low-dose ouabain also activates a signaling pathway
involving Src, ERK, and Akt that promotes cell proliferation [11]. Inter-
estingly, these effects were seen in renal proximal tubule cell culture
models that expressed NHE1 (HKC-5, HK11, and OK cells), but not in
HK2 cells, a cell culture model of proximal tubule with a very low
expression of NHE1 [10]. Similarly, inhibition of NHE1 activity with
ethyl-isopropyl amiloride (EIPA) blunted the ouabain-stimulated
1090 S.J. Khundmiri et al. / Biochimica et Biophysica Acta 1843 (2014) 1089–1102increase in Na–K ATPase activity. We further demonstrated that treat-
ment with low-dose ouabain increased basolateral membrane expres-
sion and stimulated increased association of NHE1 with the Na–K
ATPase α1 subunit [10].
NHE1 is a ubiquitously expressed member of the NHE family impli-
cated in the regulation of multiple processes including intracellular pH
[12,13], cell size [14,15], and cell proliferation [16,17]. In the renal prox-
imal tubule, NHE1 expression is conﬁned to the basolateral membrane
[12], the same distribution as Na–K ATPase. NHE1 contains two well
characterized domains, an N terminal activity domain responsible for
sodium–hydrogen exchange and a C terminal scaffolding domain for
protein interactions [18]. Our previous studies suggested that at least
the activity domain of NHE1 is required for ouabain-stimulated Na–K
ATPase activity and signal transduction [10]. The demonstration that
low-dose ouabain stimulates increased association of NHE1 with Na–K
ATPase α1 subunit suggests the possibility that the scaffolding domain
is also required.
Based on these ﬁndings, we hypothesized that ouabain-stimulated
NHE1–Na–K ATPase α1 subunit association is dependent upon both
the activity and scaffolding domains of NHE1. The purpose of this
study was to determine the sites on both proteins required for their in-
teraction and function.Our data show that both the activity and scaffold-
ing domains of NHE1 are required for cardiac glycoside stimulation of
Na–K ATPase activity, and indicate that the caveolin binding motif of
the Na–K ATPase α1 subunit is critical for basolateral membrane locali-
zation of both Na–K ATPase and NHE1.We further demonstrate that theV O D D+O
100
100
50
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Fig. 1. Effect of digibind on ouabain-induced blood pressure. A, Each bar represents blood pressu
(1 μg kg bodywt.−1 day−1) for 9 days in thepresence or absence of digibind (10mg kg bodywt.−
kidney BLM preparations from the above rat groups. Data are expressed as mean ± se from six
groups as calculated by one-way ANOVA followed by Bonferroni's analysis. Right kidneys wer
ATPase α1 (D) and NHE1 (E) is shown (n = 6). All pictures were taken using a 40× objective.effects of low-dose ouabain are in fact dependent on the activation of the
Src signaling pathway.
2. Experimental procedures
2.1. Materials
Ouabain and zoniporide were purchased from Tocris (St. Louis, MO).
Digibind was purchased from GlaxoSmithKline (Parma, Italy). Antibod-
ies against caveolin-1 were purchased from Novus Biological (Littleton,
CO). The monoclonal antibody against Na–K ATPase α1 (α6F), devel-
oped by Dr. D.M. Fambrough, was obtained from the Developmental
Studies Hybridoma Bank developed under the auspices of NIHCD
and maintained by the University of Iowa, Department of Biological
Sciences, Iowa City, IA 52242. Monoclonal antibodies against NHE1
were purchased fromBDBiosciences (San Jose, CA). HRP-linked second-
ary antibodies were purchased from Vector laboratories. Streptavidin
agarose resin was purchased from Pierce Biotechnology (Rockford, IL).
Phosphatase inhibitor cocktail-1 and protease inhibitor cocktail were
purchased from Sigma (St. Louis, MO). All other chemicals were pur-
chased from Sigma, unless otherwise speciﬁed.
2.2. Animal model
All animal experiments were approved by the Institutional Animal
Care and Use Committee (IACUC) at the University of Louisville.C
re as mean± se (n= 6 in each group) in male Sprague Dawley rats treated with ouabain
1 day−1). B–D, Expression of Na–KATPaseα1 andNHE1 (B), orNa–KATPase activity (C) in
individual animals (n = 6) in each group. *Indicates P b 0.05 from vehicle-treated animal
e ﬁxed in 3.7% paraformaldehyde and embedded in parafﬁn. Representative IHC for Na–K
Na-K ATPase α1 subunit 
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Fig. 1 (continued).
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standard rat chow and water ad libitum for a week prior to experi-
ments. Animals were divided into 2 sets of 4 groups (6 animals in
each group). In each set groupA received PBS intraperitoneally (control),
group B received ouabain (1 μg kg body wt−1 day−1), group C received
digibind (10 mg kg body wt.−1 day−1) or zoniporide (1 mg kg body
wt.−1 day−1), and group D received both digibind and ouabain or
both zoniporide and ouabain for 9 days. Treatment with digibind
or zoniporide was started on the day of ouabain treatment. Blood pres-
sure was measured in ketamine-anesthetized rats after 9 days of
treatment by placing a catheter in the right carotid artery and data
were analyzed by using customized Micro-Med software as described
previously [10]. The animals were sacriﬁced and kidneys wereremoved, decapsulated, and collected in ice-cold PBS (left kidney) for
basolateral membrane (BLM) preparation or 3.7% paraformaldehyde
(right kidney) for immunohistochemistry.
2.3. Basolateral membrane isolation
Kidney cortical BLMswere prepared from the above group of rats by
the method of Sacktor et al. [19] as described previously [10].
2.4. ATP hydrolysis assay
BLM vesicles were quickly frozen in liquid nitrogen and slowly
thawed on ice to make them permeable to ATP prior to measurement
1092 S.J. Khundmiri et al. / Biochimica et Biophysica Acta 1843 (2014) 1089–1102of Na–KATPase activity. Na–KATPase activity in basolateralmembranes
was assayed as ouabain (4 mM)-sensitive ATP hydrolysis as previously
described [20]. The inorganic phosphate released was measured as
described previously [20].
2.5. Immunohistochemistry
Immunohistochemistry of kidney slices (3 μm) from the rats de-
scribed above was performed as described previously using polyclonal
antibodies against rat Na–K ATPase α1 subunit, NHE1, or appropriate
isotype control IgG (negative control) [10].
2.6. Cell culture
Human kidney proximal tubule cells HK2 (ATCC), HK8, and HK11
(a gift from Dr. Lorraine Racusen, Johns Hopkins University Baltimore,
MD), or mouse renal proximal tubule cells from wild-type (WT) and
NHE1 knock-out (SWE) animals (a gift from Dr. Jeffery Schelling, Case
Western University, Cleveland, OH) were cultured as previously de-
scribed [9]. Cells were maintained in DMEM-F12 (1:1) supplemented
with 10% FBS and 1% penicillin/streptomycin, and cultured to 90–95%
conﬂuence. Cells were washed with serum-free medium 24 h before
use. Unless otherwise stated, human kidney cells were treated for 15
min with 10 pM ouabain and mouse kidney cells were treated for 15
min with 100 nM ouabain.V O Z Z+O
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Fig. 2. Effect of zoniporide on ouabain-induced blood pressure. A, Eachbar represents blood pres
(1 μg kg body wt.−1 day−1) for 9 days in the presence or absence of zoniporide (1 mg kg body
activity (D) in kidney BLM preparation from the above rat groups. (E) Representative western
animal groups immunoprecipitated using anti-Na–K ATPaseα1 or anti-NHE1, respectively. Dat
P b 0.05 from vehicle-treated animal groups as calculated by one-way ANOVA followed by Bo
parafﬁn. Representative IHC for Na–K ATPase α1 (F) and NHE1 (G) is shown (n = 6). All pictu2.7. Ouabain-sensitive 86Rb uptake
Ouabain-sensitive 86Rb uptake in cultured cells was measured at
37 °C exactly as described previously [9,11].
2.8. Western blot analysis
Western blot was performed exactly as described previously [9,11].
2.9. Biotinylation
Surface biotinylation was performed as described previously [21].
Brieﬂy, cells were treated with ouabain for 15 min, washed with cold
PBS, and incubated with N-hydroxysulfosuccinimidobiotin (10 μl/ml)
in borate buffer, pH 9.0 (20 mM Tris, 150 mM NaCl, 10 mM boric acid,
7.2 mM KCl, 1.8 mM CaCl2) for 2 h at 4 °C. Cells were then washed 3
times with cold PBS, quenched with 100 mM glycine in PBS for 15 min
at 4 °C, and then washed 3 times more. Next, crude membranes were
isolated and resuspended in buffer containing 300 mM Mannitol,
5 mM Tris–HCl pH 7.4, 0.1% Triton X-100, and 1% (vol/vol) protease
and phosphatase inhibitor cocktails. Crude membranes were incubated
with streptavidin agarose resins overnight on a rotator at 4 °C. Proteins
bound to the resins were eluted in 1× Laemmli sample buffer and then
resolved on 10% SDS-PAGE followed by immunoblotting using mono-
clonal antibodies against Na–K ATPase α1 subunit (α6F) or NHE1.C
C B C B C B C B
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sure asmean± se (n=6 in each group) inmale SpragueDawley rats treatedwith ouabain
wt.−1 day−1). B–D, Expression of Na–K ATPase α1 and NHE1 (B and C), and Na–K ATPase
blots for NHE1 or Na–K ATPase α1 subunit in kidney BLM preparations from the above
a are expressed asmean± se from six individual animals (n= 6) in each group. *Indicates
nferroni analysis. Right kidneys were ﬁxed in 3.7% paraformaldehyde and embedded in
res were taken using a 40× objective.
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GFP- or RFP-tagged NHE1 was a kind gift from Dr. Yung-Hsiang Yi
(National Yang-Ming University, Taipei, Taiwan) [22]. mCherry-tagged
rat Na–K ATPase α1 was provided by Dr. Thomas A. Pressley and YFP-
tagged caveolin binding motif (CBM)-mutated (Phe92-XXXX-Phe97-
XX-Phe100 to Phe92-XXXX-Ala97-XX-Ala100, F97A/F100A) Na–K ATPase
α1 was provided by Dr. Zijian Xie [23]. HA-tagged NHE1 full-length,
activity-deﬁcient mutant (E266I), and scaffold-deﬁcient mutant
(KR/A) [18] were kindly provided by Dr. Dianne Barber, UCSF.
2.9.2. Transfection
SWE cells were transfected with the indicated plasmids using
Lipofectamine-2000 (Invitrogen) in OPTI-MEM as described previously
[11].
2.9.3. Sensitized FRET
Försters' Resonance Energy Transfer (FRET) imaging experiments
were performed in living cells. SWE cells were transfected with GFP-
NHE1 (donor) and mCherry-Na–K ATPase α1 (acceptor) for 24 h and
then viewed and analyzed with an Olympus FRET/TIRF microscope
(Center Valley, PA). FRET image acquisition and analysis were per-
formed using SlideBook software version 4.2 as described previously
[24]. The software is based on the three-ﬁlter “micro-FRET” image sub-
traction method described by Jiang and Sorkin [25]. Brieﬂy, three im-
ages (100-ms or 250-ms exposure sets, 2 × 2 binning) were obtained:
an mCherry excitation/mCherry emission image; a GFP excitation/GFP
emission image; and a GFP excitation/mCherry emission image (raw,
uncorrected FRET). After imaging, background images were taken.
Background-subtracted mCherry and GFP images were fractionally
subtracted from raw FRET images based on measurements for GFP
bleed-through (0.50–0.56) and mCherry cross-excitation (0.015–0.02).
This fractional subtraction generates corrected FRETC images. The
corrected images were represented in pseudo-color (gated to mCherry
acceptor levels), showing sensitized FRET within cells. The subtraction
Pearson's coefﬁcients were rounded up from average cross-bleed valuesdetermined in cells expressing GFP- or mCherry-tagged constructs
alone. Thus, these coefﬁcients result in the underestimation of FRETC sig-
nals for true FRET partners but prevent false positive detection of FRET.
Sensitized donor or acceptor normalized FRET was calculated using
SlideBook4.2 software.
2.9.4. TIRF microscopy
Membrane Total Internal Reﬂection Fluorescence (TIRF) was per-
formed as described by Blaine et al. [26] with slight modiﬁcations.
Brieﬂy, SWE cells were grown to 60% conﬂuence in a dish with a
collagen-coated coverslip bottom (no. 1.5, MatTek, Ashland, MA). Cells
were transfected with the indicated plasmids as described in Results.
Samples were observed using an Olympus TIRF microscope equipped
with a 60× 1.45 numerical aperture (NA) objective under the control
of SlideBook software (version 4.2, Olympus, Center Valley, PA). Laser
excitation was derived from a multiline argon ion laser run at the
same current setting for all experiments. The power at the sample was
controlled by a neutral density ﬁlter wheel. Excitation and emission
wavelengths were selected using ﬁlters set for mCherry and GFP. The
laser was aligned per the manufacturer's instructions to achieve TIRF il-
lumination. Images were taken using a Hamamatsu camera operating
with 2 by 2 binning. Oxygen was provided by the ambient air, which
was supplemented by 5% CO2 andwarmed to 37 °C in an environmental
chamber surrounding the specimen.
2.9.5. Protein determination
Protein concentration was determined using a bicinchoninic acid
protein assay kit (Sigma) using BSA standard.
2.9.6. Statistics
Data are shown as mean ± SE. The n values represent the number
of independent experiments. Each experiment was performed in trip-
licate. P values were calculated using one-way ANOVA, followed by
Bonferroni analysis using GraphPad Prism software. A P value b0.05
was a priori considered statistically signiﬁcant.
niabauOelciheV
auO+inoZediropinoZ
Isotype Control
NKAα1 subunit
F
NHE1
G
niabauOelciheV
auO+inoZediropinoZ
Isotype Control
Fig. 2 (continued).
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3.1. Effect of ouabain on blood pressure
We have previously demonstrated that treatment of rats with
low-dose ouabain increases blood pressure after 9 days [10]. To de-
termine whether this effect is due to the cardiac glycoside propertiesFig. 3. Effect of NHE1 and Src kinase on ouabain-stimulated signaling in renal proximal tubule c
and WT cells) ouabain in the presence or absence of the Src kinase inhibitor PP2 (1 μM). Cell
(top panel), Src (middle panel), or ERK1/2 (bottom panel) bywestern blot using phospho-speci
against the total protein. A representative blot is shown (n=4). Bar diagrams showarbitrary de
experiments. The values were plotted as fold difference from the vehicle-treated group. *Indica
panels show representative immunoblots for Na–K ATPase α1 and NHE1 in crude membraneof ouabain, we treated male Sprague–Dawley rats with ouabain in
the presence or absence of digibind, an FDA-approved antibody
against cardiac glycosides to treat cardiac glycoside toxicity [27].
As shown in Fig. 1A, treatment with ouabain increased blood pres-
sure, which was prevented by treatment with digibind. Ouabain-
mediated increase in Na–K ATPase α1 expression (Fig. 1B) and activity
(Fig. 1C) in isolated renal tubular BLMswas also prevented by treatmentells. Cells were treated for 15min with 10 pM (A, HK2 and HK11 cells) or 100 nM (B, SWE
s were lysed and nuclear-free extracts were used to determine phosphorylation of EGFR
ﬁc antibodies. The nitrocellulosemembraneswere stripped and reprobed using antibodies
nsitometry values (mean± se) as ratio of phospho to total expression from4 independent
tes P b 0.05 as calculated by one-way ANOVA followed by Bonferroni analysis. A & B, right
preparations from untreated HK2, HK11, WT, and SWE cells.
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Fig. 4. Effect of NHE1 inhibition on ouabain-stimulatedNa–KATPase activity in renal proximal tubule cells. Three human kidney proximal tubule cell lines (HK2, HK8, or HK11)were treated for
15 min with ouabain (10 pM) in the presence or absence of zoniporide (1 μM). Ouabain (1 mM)-sensitive 86Rb uptake was determined as a measure of Na–K ATPase-mediated ion transport.
Each bar represents data (mean ± se) from 6 individual experiments (n = 6) performed in triplicate. *Indicates P b 0.05 as calculated by one-way ANOVA followed by Bonferroni analysis.
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that the increase in Na–K ATPase α1 subunit (Fig. 1D) and NHE1
(Fig. 1E) expression in kidney tubules by ouabain was prevented by
digibind.
3.2. Effect of NHE1 inhibition on ouabain-induced blood pressure
We have previously demonstrated that treatment with ouabain
increases phosphorylation of NHE1, indicating that ouabain increases
NHE1 activity [10]. To determine if NHE1 activity is required for the
ouabain-mediated increase in blood pressure, animals were treated
with ouabain in the presence or absence of zoniporide, a speciﬁc NHE1
inhibitor. As shown in Fig. 2A, zoniporide completely prevented the
ouabain-stimulated increase in blood pressure. Zoniporide also blocked
the ouabain-mediated increase in expression (Fig. 2B, D, & E) and activity
(Fig. 2C) of Na–K ATPase α1 in renal basolateral membranes. Of note,
zoniporide decreased basal expression of NHE1 in addition to blocking
the ouabain-mediated effect on this protein (Fig. 2B, D & F).
3.3. Effect of NHE1 inhibition on ouabain-induced 86Rb uptake and
signaling pathway activation
Our prior studies, using a relatively nonspeciﬁc inhibitor of NHE1,
had suggested that ouabain-mediated stimulation of Na–K ATPase ac-
tivity and signal transduction pathway activation were dependent on
NHE1 [10]. To directly test the requirement for NHE1 in ouabain signal-
ing, we compared low-dose ouabain responses between NHE1-null cell
lines with NHE1-expressing cell lines.
The NHE1-deﬁcient proximal tubule cell lines used are the human
HK2 cells and mouse SWE cells, while NHE1-replete cell lines used are
the human HK11 cells and mouse WT cells. SWE cells are derived
from NHE1-knockout mice and WT cells are derived from wild-type
littermates of NHE1-knockout mice. To determine if a lack of NHE1 ex-
pression affects Na–KATPase expression,we determined the expression
of Na–K ATPaseα1 andNHE1 in human andmouse kidney proximal tu-
bule cell lines. As shown in Fig. 3A & B right-hand panels, a lack of NHE1
expression does not affect basal expression of Na–KATPaseα1 subunits.
The cellswere treated for 15minwith either 10 pM (human) or 100 nM
(mouse) ouabain followed by western blot analysis of EGFR, Src, and
ERK phosphorylation. As shown in Fig. 3, ouabain increased phosphory-
lation of EGFR, Src, and ERK in HK11 and WT cells. Pretreatment with
the Src inhibitor PP2 prevented the increase in EGFR, Src, and ERKFig. 5. Effect of NHE1 and Src kinase on ouabain-stimulated Na–KATPaseα1 expression in kidney
100 nM(B, SWE andWT cells) ouabain in the presence or absence of PP2 (1 μM) and cell surface
SDS-PAGE and analyzed by immunoblot using Na–K ATPaseα1 subunit (upper panel), caveolin-
from the vehicle-treated group represent densitometry data from three independent experimen
Bonferroni analysis.phosphorylation. However, neither ouabain nor PP2 had any effect on
ouabain-stimulated EGFR, Src, and ERK phosphorylation in cells lacking
NHE1 expression (HK2 and SWE). Interestingly, basal Src, EGFR, and
ERK phosphorylation and total expression were signiﬁcantly higher in
both NHE1-deﬁcient HK2 and SWE cells than NHE1-replete HK11 and
WT mouse proximal tubule cells.
Pharmacological inhibition of NHE1 in the human proximal tubule
cell lines by zoniporide (HK2, HK8, or HK11) blocked the ouabain-
mediated increase in 86Rb uptake in the NHE1-replete cells (HK8 and
HK11). As expected, neither ouabain nor zoniporide had any effect on
86Rb uptake in NHE1-null HK2 cells (Fig. 4). Of note, the basal Na–K
ATPase-mediated 86Rb uptake in NHE1-null cells (HK2 cells) was not
signiﬁcantly different from NHE1-expressing (HK8 or HK11) cells.
3.4. Requirement of NHE1 and Src phosphorylation in ouabain-stimulated
Na–K ATPase α1 membrane expression
Our data support a requirement for NHE1 in mediating the effects of
low-dose ouabain on Na–K ATPase function. To further validate the role
of NHE1, we examined the relationship between ouabain-stimulated
NHE1 expression, Na–K ATPase expression, and Src phosphorylation in
the NHE1-null (HK2 and SWE) and -replete (HK11 and WT) cell lines.
Cells were treated for 15 min with ouabain in the presence or absence
of PP2. Cells were then subjected to surface biotinylation followed
by precipitation of biotinylated proteins using streptavidin beads and
analyzed by western blot for Na–K ATPase α1, caveolin-1, or NHE1. As
shown in Fig. 5, ouabain increased the membrane expression of Na–K
ATPase α1, caveolin-1, and NHE1 in HK11 and WT cells. Pretreatment
with PP2 abolished the increase inmembrane expression of all three pro-
teins. However, neither ouabain nor PP2 had any effect on the expression
of any of the proteins studied in the NHE1-null HK2 and SWE cells.
3.5. Association between Na–K ATPase α1 and NHE1
Using immunoprecipitation, we have previously demonstrated that
treatment with low dose ouabain increases the association between
Na–K ATPase α1 and NHE1 [10]. To determine the nature and local-
ization of this association, NHE1-null SWE cells were transiently
transfected with mCherry-tagged rat Na–K ATPase α1 and GFP-tagged
human NHE1. FRET or TIRF microscopy was performed in live cells be-
fore and after treatment with 100 nM ouabain. As shown in Fig. 6A,
epiﬂuorescence showed that both proteins were expressed in theproximal tubule cells. Cells were treated for 15minwith 10 pM (A, HK2 andHK11 cells) or
was biotinylated as described inMethods. Crudemembrane proteinswere separated by 10%
1 (middle panel), or NHE1 (lower panel) antibodies. Values (mean± se) as fold difference
ts as Arbitrary Units (AU). *Indicates P b 0.05 as calculated by two-way ANOVA followed by
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imity even under basal conditions, and that the interaction between
the two increased after treatmentwith ouabain (Fig. 6B). Quantiﬁcation
of data showed that sensitized FRET efﬁciency after photobleaching in-
creased signiﬁcantly after ouabain treatment (Fig. 6C). Ouabain also
stimulated a dramatic change in the pattern of protein expression as
seen in Fig. 6A and D. To determine if ouabain increases basolateral
membrane expression of Na–K ATPase α1 and NHE1, TIRF microscopy
was performed in the same cells following FRET microscopy. As shown
in Fig. 6D, treatment with ouabain increased expression and association
between Na–K ATPase α1 and NHE1 in the membrane compartment.
3.6. Molecular domains of Na–K ATPase α1 and NHE1 involved in
ouabain-stimulated association
To identify the molecular domains in Na–K ATPase α1 required for
association with NHE1, YFP-tagged CBM mutant of Na–K ATPase α1
(pseudo color green) and full-length RFP-tagged NHE1 (red color)
were transfected in SWE cells. Epiﬂuorescence and TIRF microscopy
were performed before and after treatment with 100 nM ouabain. As
shown in Fig. 7A, epiﬂuorescence showed that both Na–K ATPase α1
and NHE1 are expressed in transfected cells and the expression did
not change after treatment with ouabain. However, TIRF microscopy
showed that the CBM mutant of Na–K ATPase α1 was not expressedin the basolateral membrane. Treatmentwith ouabain failed to increase
themembrane expression of Na–KATPaseα1. Interestingly, transfection
of CBM-mutant Na–KATPaseα1 prevented themembrane expression of
NHE1, suggesting that expression of the caveolin binding motif of the
Na–K ATPase α1 subunit is critical for membrane expression of both
Na–K ATPase α1 and NHE1 (Fig. 7B).
NHE1 expresses a distinct N-terminal activity domain and a
C-terminal scaffolding domainwhich facilitate formation of signalosomes
[18]. To determine if either or both the activity and scaffold domains of
NHE1 are required for Na–K ATPase stimulation by low-dose ouabain,
NHE1-deﬁcient SWE cells were transiently transfected with HA-tagged
full-length wild type, activity-domain-mutated (E266I), or scaffold-
domain-mutated (KR/A) NHE1 constructs in pCMV vector. Expression
was conﬁrmed by western blot using anti-HA tag antibodies (data not
shown). Transfected cells were treated for 15 min with 100 nM ouabain,
and Na–K ATPase-mediated 86Rb uptake was measured. As controls, WT
(positive control), SWE (negative control), or SWE cells transfected
with vector only (negative control) were also analyzed along with the
cells transfected with NHE1. As shown in Fig. 7C, treatment with ouabain
increased Na–K ATPase-mediated 86Rb uptake in WT and SWE cells
transfected with full length NHE1. Treatment with ouabain did not have
any effect on 86Rb uptake in SWE cells transfected with vector or
activity-domain-mutated NHE1 (E266I) cells. Paradoxically, low-dose
ouabain signiﬁcantly decreased Na–K ATPase-mediated 86Rb uptake in
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determine whether mutations in NHE1 affect association with Na–K
ATPase α1 subunit, crude membranes from transfected cells treated
with vehicle or ouabain were prepared and immunoprecipitated using
anti-HA antibodies, followed by western blot for the Na–K ATPase α1
subunit. As shown in Fig. 7D, ouabain increased the association between
the Na–K ATPase α1 subunit and NHE1 in cells transfected with full
length (WT) NHE1 and activity-deﬁcient-mutant NHE1 (E266I), but notNa-K ATPase α1
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subunit as well as both the activity and scaffolding domains of NHE1.
Using NHE1-deﬁcient cell lines, we have directly shown a requirement
for NHE1 for activation of the EGFR/Src/ERK/Akt pathway by low-dose
ouabain. These ﬁndings have signiﬁcant implications for understanding
the regulation of proximal tubule transepithelial ion transport and sodi-
um homeostasis.
The Na–K ATPase is the key regulator of sodium reabsorption in the
proximal tubule, where greater than 60% of renal sodium reabsorption
occurs [28]. Relatively small changes in transport at this site have the
ability to effect major changes in ion homeostasis. In the renal proximal
tubule, Na–KATPase is heavily regulated by hormones [29], neurotrans-
mitters [30,31], and cardiac glycosides [32,33].While initially thought to
have solely an inhibitory effect on the Na–K ATPase activity, cardiac gly-
cosides are now recognized as instigators of a signaling pathway in-
volved in the regulation of cell proliferation and survival [4,6,7,9,11].
The involvement of NHE1 in this function is ﬁtting, in that NHE1 has
been implicated in a variety of cell functions, including maintenance
of intracellular pH, growth, and survival [12–18]. Interestingly, the con-
centrations of ouabain and some other cardiac glycosides that stimulate
this signaling pathway are considerably lower than the concentrations
that inhibit the pump. How the stimulatory effect of ouabain on the
Na–K ATPase activity interfaces with the other well-known regulatory
factors is not understood. Furthermore, whether all cardiac glycosides
have a similar effect is not clear.
FRET analysis is consistent with a direct interaction between NHE1
and the α1 subunit of Na–K ATPase. Analysis of proteins with deﬁned
mutations implicates the caveolin binding motif of Na–K ATPase α1
and both the activity and scaffolding domains of NHE1 as crucial ele-
ments for ouabain-induced α1-NHE1 association. However, our data
do not allow us to draw the conclusion that the caveolin binding motif
of Na–K ATPase α1 interacts with speciﬁc sites within the activity and/
or scaffolding domains of NHE1. The failure of the caveolin-binding-
motif-mutated Na–K ATPase α1 subunit to show normal expression
at the basolateral membrane suggests that one reason for the lack of in-
teraction between themutatedNa–KATPaseα1 andNHE1 is simply ab-
normal localization of Na–K ATPase α1. Likewise, the failure of ouabain
to stimulate Na–K ATPase activity with NHE1 that lacks a functionalactivity domainmay suggest that the interaction between Na–K ATPase
α1 and NHE1 occurs in that domain; however, another potential expla-
nation is that ouabain-stimulated NHE1 activity facilitates interaction at
another site. The effect of the scaffolding domain NHE1 mutant on the
response to ouabain is of some interest. Absence of a functional scaffold-
ing domain abolished the stimulatory effect of ouabain on Na–K ATPase
activity and uncovered an inhibitory effect of low-dose ouabain on
Na–K ATPase activity, suggesting that the scaffolding domain of NHE1
may regulate the sensitivity of Na–K ATPase to ouabain. The increased
association between Na–K ATPase and NHE1 with KR/A mutation
would suggest that the association probably occurs at a site other than
the putative scaffolding domain of NHE1. Further studies are required
to conﬁrm this conclusion.
The investigations into the signaling pathway suggest other roles for
NHE1 vis a vis regulation of Na–K ATPase function. The phosphorylation
status and total expression of EGFR, Src, and ERK in the NHE1-null HK2
and SWE cells were signiﬁcantly higher under basal conditions than
HK11 and wild type mouse proximal tubule cells. In contrast to HK11
and wild type mouse proximal tubule cells, the NHE1-deﬁcient cell
types (HK2 and SWE) showed no increase in phosphorylation of these
signaling compounds in response to ouabain treatment. These data
may suggest that total ablation of NHE1 expressionmay evoke compen-
satory changes in regulatory pathways. This is probably not unexpected
given its likely role in adjusting ionic homeostasis and cell proliferation.
These data may also suggest that the NHE1/Na–K ATPase complex se-
questers Src under basal conditions but upon treatmentmay release ac-
tivated Src to phosphorylate EGFR anddownstream signaling pathways.
However, further studies are required to conﬁrm this conclusion.
Our studies suggest that the increase in 86Rb uptake by low dose
ouabain is accompanied with an increase in membrane expression of
Na–K ATPase. The increase in expression of Na–K ATPase required
NHE1 expression and activity as inhibition of NHE1 by zoniporide
prevented the increase in Na–K ATPase membrane expression. Cell cul-
ture studies suggest that the increase in expression was dependent
upon Src kinase. We have previously demonstrated that treatment
with low dose ouabain increases phosphorylation of the Na–K ATPase
α1 subunit and NHE1 [10]. Taken together, the data suggest that
phosphorylation of Na–K ATPase and NHE1 through Src dependent
mechanisms increases translocation of Na–K ATPase and NHE1. Further
studies using mutations at speciﬁc sites are required to conﬁrm this
conclusion.
In summary we have described an ouabain-stimulated direct inter-
action between Na–K ATPase α1 subunit and NHE1 which is critical
for ouabain-stimulated Na–K ATPase activity and signal transduction.
The regulatory role for NHE1 in these processes suggests potential ther-
apeutic targets for regulation of both proximal tubule sodium transport
and cell survival and proliferation.
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